TY - JOUR
KW - morphine
KW - naloxone
KW - Addiction
KW - Withdrawal
KW - Motor Activity
KW - Empirical Study
KW - Quantitative Study
KW - Animal
KW - Male
KW - Motor Processes
KW - Drug Dependency
KW - Animal Development
KW - Rats
KW - Opiates
KW - article
KW - 2580:Psychopharmacology
AU - Rahul Raghav
AU - Raka Jain
AU - Anju Dhawan
AU - T. S. Roy
AU - Punit Kumar
A1 - 
AD - National Drug Dependence Treatment Centre, Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India rakajain2009@gmail.com; Department of Anatomy, All India Institute of Medical Sciences, New Delhi, India ; Jain, Raka,New Delhi,India,110029,National Drug Dependence Treatment Centre, Department of Psychiatry, All India Institute of Medical Sciences,rakajain2009@gmail.com
BT - Pharmacology, Biochemistry and Behavior
C5 - Measures; Medically Unexplained Symptoms; Opioids & Substance Use
DO - 10.1016/j.pbb.2018.10.001
JF - Pharmacology, Biochemistry and Behavior
LA - English
M1 - Journal Article
PB - Elsevier Science
PY - 2018
SN - 0091-3057, 0091-3057
SP - 130
EP - 138
EP - 
T1 - Chronic co-administration of nalbuphine attenuates the development of opioid dependence
T2 - Pharmacology, Biochemistry and Behavior
TI - Chronic co-administration of nalbuphine attenuates the development of opioid dependence
U1 - Measures; Medically Unexplained Symptoms; Opioids & Substance Use
U3 - 10.1016/j.pbb.2018.10.001
VL - 175
VO - 0091-3057, 0091-3057
Y1 - 2018
Y2 - 12
ER -